GRIFFONIA E.S
Food supplement declared in France, declaration No 2020-12-1025, decision dated 17 December 2020
GRIFFONIA E.S is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- not provided
- Food business operator placing the product on the market
- TAILORPHARMA SAS
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 2 gélules
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Sous antidépresseurs
- Objectives stated by the manufacturer (these are not authorised claims)
- Système nerveux
Declaration 309784, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Substance interdite
Griffonia simplicifolia (DC.) Baill.: dangerous plant prohibited in food in Belgium (list 1).
Source: Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), arrêté royal du 31 août 2021, annexe remplacée le 30 janvier 2024, liste 1, page PDF 73.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Griffonia simplicifolia (DC.) Baill. | Semence | Extrait sec hydroalcoolique | 300 mg |
Additives
Hydroxypropyl Méthyl Cellulose
Other ingredients
maltodextrine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Contre-indication pour les femmes enceintes ou allaitantes et les personnes sous traitement anti-dépresseurs.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.